Skip to content

Immuno-oncological treatments

Immuno-oncological treatments refer to cancer treatments (drugs) whose purpose is to strengthen the body's own immune response against cancer.

Previously used immunomodulators include interferon, used for the treatment of cancers such as melanoma. The new-generation immuno-oncological treatments are based on a different mechanism. They, too, were first used for the treatment of melanoma. Research data used as the basis for a marketing authorisation have so far been reported for melanoma, lung cancer and kidney cancer. In addition, preliminary research results have been reported, and more extensive studies on a number of other cancers are underway.

Currently, these new-generation immuno-oncological drugs include the CTLA-4 antibody ipilimumab, the PD-1 antibody pembrolizumab and the PD-1 antibody nivolumab. In addition, there are many therapies that are still being studied and have not yet been launched on the market. Oncolytic viruses constitute another group of immuno-oncological therapies. The first of these therapies to achieve a marketing authorisation is talimogene laherparepvec.

Docrates a forerunner in immuno-oncological treatments

Docrates Cancer Center started immuno-oncological treatments already in March 2015, using pembrolizumab. After this, we have also started nivolumab treatments. In addition, we have started or are about to start a number of drug trials with immuno-oncological treatments. You will find more information about our ongoing clinical trials here. Docrates has gained experience in oncolytic adenovirus research and treatments since 2007. Docrates was the first European centre with a certification for oncolytic herpes virus treatments.

Read more

The number of Norwegian patients increased in 2023

Docrates Cancer Center has been treating Finnish and international patients in Helsinki for more than 15 years. In 2023, the...

Read more

Docrates’ new workwear improves work satisfaction and patient safety

Docrates Cancer Center joined forces with Medanta, a pioneer in healthcare workwear, to create a more functional workwear collection for...

New interview methodologies help cancer patients and their spouses deal with challenging circumstances

Riikka Talsi, M.Sc. (Tech), who defended her doctoral thesis at Aalto University School of Science, Department of Industrial Engineering and...

When suspecting cancer, a prompt diagnosis and support is important – our oncologists are here to help

Cancer. The word alone makes the heart beat faster and fills people's minds with questions. What if I have cancer?...

Why come to Docrates Cancer Center?

  • Top cancer experts and effective treatments without delay.
  • Individual care. You have your own care team - your doctor and your nurse.
  • Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
  • Experience in treating international patients from over 60 countries. Multilingual personnel.
+358 10 773 2010

Contact us!

Mon-Thu 8:00-18:00, Fri 8:00-16:00